Pelvic Floor Dysfunctions

4

Review clinical trials related to Pelvic Floor Dysfunctions. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Postpartum Exercise Intervention

The postpartum period is associated with decreases in physical activity levels, muscular strength, muscular endurance, and pelvic floor muscle function, but little scientific evidence exists on how best to initiate and progress exercise in the postpartum period. This proposal aims to improve habitual physical activity levels, neuromuscular health (i.e., strength, fatigability, symptom burden) and overall wellbeing (i.e., decreased fear of movement, improved sleep quality, improved perception of quality of life) through participation in a weekly exercise program. This study will help to inform postpartum exercise recommendations and is novel as it allows participants to incorporate their children into the exercise routine, thus removing a primary barrier to physical activity/exercise.

Participants needed: 50
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Carroll UniversityUpdated: May 29, 2026Locations: 1
Eligibility criteria

18 years of age or older [+1]

less than 6 weeks postpartum or not medically appropriate to engage in exercise... [+6]

Status: Not yet recruiting

Adapted Physical Activity and Pelvic Floor Function for Pelvic Girdle Pain During Pregnancy

Pelvic girdle pain (PGP) is a common condition during pregnancy, affecting up to two-thirds of women. It can cause significant discomfort, limit daily activities, and reduce quality of life. Current treatment options are limited, and many women continue to experience pain throughout pregnancy and even after childbirth. This study will evaluate whether a structured program of adapted physical activity, with additional individualized pelvic floor rehabilitation when needed, can reduce pelvic girdle pain and improve function during pregnancy. The intervention consists of weekly 60-minute sessions of adapted physical activity, led by a pelvic health physiotherapist, from inclusion until 36-38 weeks of gestation. The exercises focus on lumbopelvic stability, mobility, strengthening, and safe aerobic activity. If a participant presents with pelvic floor dysfunction, individualized rehabilitation may be added in parallel. Participants will be randomly assigned to either the intervention group (adapted physical activity ± pelvic floor rehabilitation) or a control group. The control group will receive standard pregnancy follow-up care plus a validated flyer with international recommendations on physical activity during pregnancy but without supervised sessions. The primary outcomes are pain intensity and functional impact of PGP, measured using the Visual Analog Scale (VAS) and the Pelvic Girdle Questionnaire (PGQ). Secondary outcomes include self-reported physical activity, pelvic symptoms, pelvic floor function, adherence to the intervention, and acceptability of the program. A total of 40 pregnant women will be enrolled at Hospital La Tour in Geneva, Switzerland. Assessments will take place at three time points: inclusion (≤27 weeks of gestation), late pregnancy (36-38 weeks), and 3 months after delivery. The study is expected to provide new evidence on the benefits of integrating pelvic floor functionality into physical activity programs for pregnant women with PGP. If effective, this approach could inform clinical practice and improve care for women during pregnancy

Participants needed: 40
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Haute Ecole de Santé VaudUpdated: Sep 22, 2025
Eligibility criteria

Pregnant women aged ≥18 years [+3]

Isolated low back pain without pelvic involvement [+4]

Status: Not yet recruiting

Effectiveness of Modern Physical Agents in the Treatment of Pelvic Floor Dysfunctions

This clinical trial aims to determine whether adding modern physical agents (high-intensity laser therapy, magnetotherapy, radial shock wave therapy, kinesiotaping) in conjunction with classical rehabilitation interventions produces superior outcomes in treating pelvic floor dysfunction compared to classical rehabilitation interventions alone. It will also assess the safety of these agents in the context of pelvic floor dysfunction rehabilitation. The main questions it aims to answer are: Does adding modern physical agents to the treatment of pelvic floor dysfunction improve symptoms, impairments in functional state, quality of life, and biosocial functions more effectively than classical interventions alone? Participants who experience pelvic floor dysfunction during primary rehabilitation will receive: Either an individualized rehabilitation intervention plan comprising 20 classical procedures in combination with modern physical agents or classical interventions alone. Rehabilitation will take place in the outpatient rehabilitation department. Patients will visit the clinic for a comprehensive functional state assessment and then for individualized procedures; the entire plan will be delivered over three months, after which participants will return for follow-up checkups and assessments after the procedures and again after six months.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Lithuanian University of Health SciencesUpdated: Jan 29, 2025Locations: 1
Eligibility criteria

Patients older than 18 years old. [+3]

Oncological diseases or being actively investigated for oncological diseases. [+6]

Status: Recruiting

Effect of Brief-tele Support on Attendance at Physiotherapy Sessions

Patients on the waiting list for physiotherapy treatment for pelvic floor dysfunction will be randomly divided into three groups: * a group that gets a telephone call before their invitation letter is sent. * a group that gets a telephone call after their invitation letter is sent. * a group that does not receive a telephone call. The phone call is a brief 5-10 minute call, which will be semi-structured. It will remind the patient of their appointment time, it will outline what the treatment involves and highlight the potential benefits and drawbacks, and allow the patient to ask questions about the treatment.

Participants needed: 500
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Swansea UniversityUpdated: Dec 2, 2024Locations: 1
Eligibility criteria

Women on waiting list for pelvic floor dysfunction [+1]